H. B. Fuller (NYSE:FUL) Upgraded by JPMorgan Chase & Co. to “Overweight” Rating

H. B. Fuller (NYSE:FUL) was upgraded by investment analysts at JPMorgan Chase & Co. from a “neutral” rating to an “overweight” rating in a research note issued on Friday. The brokerage currently has a $67.00 price objective on the specialty chemicals company’s stock. JPMorgan Chase & Co.‘s price objective would indicate a potential upside of 8.17% from the company’s current price.

FUL has been the topic of a number of other reports. Citigroup lifted their target price on H. B. Fuller from $67.00 to $70.00 and gave the stock a “buy” rating in a report on Monday, March 30th. Wall Street Zen upgraded H. B. Fuller from a “hold” rating to a “buy” rating in a research report on Sunday, March 29th. UBS Group lifted their price target on H. B. Fuller from $63.00 to $71.00 and gave the stock a “neutral” rating in a research note on Wednesday, June 17th. Vertical Research upgraded H. B. Fuller from a “hold” rating to a “strong-buy” rating in a report on Friday, March 27th. Finally, Royal Bank Of Canada set a $58.00 price objective on shares of H. B. Fuller in a research note on Wednesday, May 27th. One research analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and two have assigned a Hold rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average price target of $67.86.

H. B. Fuller Stock Performance

Shares of FUL opened at $61.94 on Friday. The firm’s 50 day moving average is $61.60 and its 200-day moving average is $61.28. The stock has a market capitalization of $3.38 billion, a P/E ratio of 20.44, a P/E/G ratio of 0.85 and a beta of 0.96. The company has a debt-to-equity ratio of 1.01, a current ratio of 1.92 and a quick ratio of 1.15. H. B. Fuller has a 12-month low of $48.71 and a 12-month high of $68.63.

H. B. Fuller (NYSE:FUL) last issued its earnings results on Wednesday, June 24th. The specialty chemicals company reported $1.41 earnings per share for the quarter, topping analysts’ consensus estimates of $1.37 by $0.04. The firm had revenue of $950.27 million during the quarter, compared to analysts’ expectations of $924.83 million. H. B. Fuller had a net margin of 5.29% and a return on equity of 12.29%. The firm’s revenue for the quarter was up 5.8% compared to the same quarter last year. During the same period last year, the firm posted $1.18 earnings per share. H. B. Fuller has set its FY 2026 guidance at 4.600-4.900 EPS. Equities research analysts anticipate that H. B. Fuller will post 4.78 EPS for the current fiscal year.

Insider Activity

In other H. B. Fuller news, CEO Celeste Beeks Mastin bought 5,170 shares of the firm’s stock in a transaction dated Tuesday, April 7th. The stock was acquired at an average price of $57.08 per share, with a total value of $295,103.60. Following the completion of the transaction, the chief executive officer directly owned 8,670 shares in the company, valued at approximately $494,883.60. This represents a 147.71% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 1.83% of the stock is owned by insiders.

Institutional Investors Weigh In On H. B. Fuller

Hedge funds have recently bought and sold shares of the business. Allworth Financial LP boosted its position in H. B. Fuller by 50.1% during the 4th quarter. Allworth Financial LP now owns 578 shares of the specialty chemicals company’s stock worth $34,000 after acquiring an additional 193 shares during the period. Hantz Financial Services Inc. increased its holdings in shares of H. B. Fuller by 432.9% in the 4th quarter. Hantz Financial Services Inc. now owns 778 shares of the specialty chemicals company’s stock valued at $46,000 after purchasing an additional 632 shares during the period. Aster Capital Management DIFC Ltd purchased a new stake in shares of H. B. Fuller in the fourth quarter worth approximately $46,000. Torren Management LLC purchased a new stake in shares of H. B. Fuller in the fourth quarter worth approximately $52,000. Finally, Brown Brothers Harriman & Co. acquired a new stake in shares of H. B. Fuller during the third quarter worth approximately $56,000. 95.93% of the stock is owned by hedge funds and other institutional investors.

H. B. Fuller News Roundup

Here are the key news stories impacting H. B. Fuller this week:

• Positive Sentiment: H. B. Fuller reported second-quarter results that beat expectations, with EPS of $1.41 versus $1.37 consensus and revenue of $950.27 million versus $924.83 million estimated. The company also raised its FY2026 EPS guidance to $4.60-$4.90, supporting the case that core operations remain healthy. Article Title
• Neutral Sentiment: The company’s updated outlook was close to Wall Street’s expectations, which may limit how much of a positive reaction investors assign to the earnings beat alone.
• Negative Sentiment: Sentiment was pressured by H. B. Fuller’s agreement to buy Advanced Medical Solutions in a cash deal valued at about £715 million ($942 million), a transaction some investors view as aggressive and likely to add integration and financing risk. Article Title
• Negative Sentiment: Ancora publicly criticized the acquisition, calling it reckless and accusing management of ignoring shareholder opposition, which adds governance uncertainty and could weigh on the stock. Article Title
• Negative Sentiment: Investors are also digesting a new 10-K risk disclosure flagging “material emerging risks,” which can raise concerns about future volatility and execution risk. Article Title

H. B. Fuller Company Profile

H. B. Fuller Company, founded in 1887 and headquartered in St. Paul, Minnesota, is a global adhesives and specialty chemical solutions provider serving a wide array of industries. The company develops, manufactures and markets adhesive technologies, sealants, polymers and related chemical products designed to enhance product performance, sustainability and manufacturing efficiency.

Fuller’s product portfolio spans multiple market segments, including packaging and converting, general industrial assembly, electronics, transportation, hygiene and construction.